ARCHIVES

Scientists, Advocates Voice Objections To von Eschenbach’s Conflicts, 2015.

This article is from The Cancer Letter archive.

Vol. 32 No. 42 | November 22, 2006

Download PDF Visit The Full Archive

Related Articles

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

Guest Editorial: Group Chairs Urge Implementation of NCI plan. Next Step: Bioinformatics and Tissue Banks

November 11, 2011

NCI, SAIC To Support Contracts For Molecular Target Labs.

February 25, 2000

NIh Clinical Center Urged To Create Governing Board

March 15, 1996

Campath Improves PFS In B-Cell CLL In Phase III Trial

January 26, 2007

Unclear Whether Clinical Trials Benefit Patients, Review Finds

February 27, 2004